Search Results 111-120 of 18124 for CLL
-
Description. Ibrutinib is used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL)/small ...
-
Lindsey Roeker, M.D., is a board-certified hematologist / oncologist and clinical researcher focusing on chronic lymphocytic leukemia (CLL) and Richter's ...
-
The purpose of this study is to define the presence and role of Axl in the risk of skin cancers in patients with CLL as well as non-CLL patients.
-
A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
-
The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...
-
This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Zanubrutinib is also used in combination with ...
-
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
-
This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or R/R SLL pretreated with ...
-
He is board certified in internal medicine and hematology and has a special interest in chronic lymphocytic leukemia (CLL) and related disorders. Dr. Parikh ...
-
Interests · Chronic lymphocytic leukemia · Non-Hodgkin lymphoma · Hodgkin lymphoma · Hairy cell leukemia · T-cell prolymphocytic leukemia · Chimeric antigen receptor ...